513
Participants
Start Date
July 31, 2011
Primary Completion Date
June 30, 2014
Study Completion Date
February 28, 2015
Anamorelin HCl
Placebo
Corona
Fountain Valley
Fullerton
Glendale
La Jolla
Riverside
Washington D.C.
Orange City
Quincy
Indianapolis
Louisville
Boston
Lake Success
Durham
Cleveland
Sylvania
West Reading
Charleston
Falls Church
Prairiewood
Adelaide
East Bentleigh
Victoria
Brest
Lesnoy
Minsk
Antwerp
Brussels
Genk
Ghent
Liège
Edmonton
Sault Ste. Marie
Toronto
Montreal
Benešov
Brno
Hlučín
Liberec
Nymburk
Lyon
Villejuif
Großhansdorf
Halle
Budapest
Kassai
Beersheba
Petach Tikvah
Tel Litwinsky
Ẕerifin
Piacenza
Bydgoszcz
Grudziądz
Katowice
Krakow
Lodz
Lublin
Szczecin
Warsaw
Krasnodar
Moscow
Saint Petersburg
Yekaterinburg
Belgrade
Kamenitz
Ljubljana
Barcelona
Seville
Valencia
Dnipropetrovsk
Kharkiv
Kyiv
Helsinn Therapeutics (U.S.), Inc
INDUSTRY